204 related articles for article (PubMed ID: 22617224)
1. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients.
Rau T; Düngen HD; Edelmann F; Waagstein F; Lainščak M; Dimković S; Apostolović S; Nešković AN; Haverkamp W; Gelbrich G; Eschenhagen T
Clin Pharmacol Ther; 2012 Jul; 92(1):21-8. PubMed ID: 22617224
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
[TBL] [Abstract][Full Text] [Related]
3. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
Yu WP; Lou M; Deng B; Song HM; Wang HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
[TBL] [Abstract][Full Text] [Related]
4. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
[TBL] [Abstract][Full Text] [Related]
5. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
6. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Stankovic I; Neskovic AN; Putnikovic B; Apostolovic S; Lainscak M; Edelmann F; Doehner W; Gelbrich G; Inkrot S; Rau T; Herrmann-Lingen C; Anker SD; Düngen HD
Int J Cardiol; 2012 Nov; 161(3):160-5. PubMed ID: 22726401
[TBL] [Abstract][Full Text] [Related]
7. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
[TBL] [Abstract][Full Text] [Related]
8. A frequent gene polymorphism affecting the heart-rate response to carvedilol.
Eschenhagen T
Pharmacogenomics; 2013 Jan; 14(2):115-8. PubMed ID: 23327570
[No Abstract] [Full Text] [Related]
9. Multiparametric comparison of CARvedilol, vs. NEbivolol, vs. BIsoprolol in moderate heart failure: the CARNEBI trial.
Contini M; Apostolo A; Cattadori G; Paolillo S; Iorio A; Bertella E; Salvioni E; Alimento M; Farina S; Palermo P; Loguercio M; Mantegazza V; Karsten M; Sciomer S; Magrì D; Fiorentini C; Agostoni P
Int J Cardiol; 2013 Oct; 168(3):2134-40. PubMed ID: 23506636
[TBL] [Abstract][Full Text] [Related]
10. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
Aygul N; Ozdemir K; Duzenli MA; Aygul MU
Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
[TBL] [Abstract][Full Text] [Related]
11. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
[TBL] [Abstract][Full Text] [Related]
12. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure -- a randomized comparison.
Galatius S; Gustafsson F; Atar D; Hildebrandt PR
Cardiology; 2004; 102(3):160-5. PubMed ID: 15334027
[TBL] [Abstract][Full Text] [Related]
14. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
Düngen HD; Apostolovic S; Inkrot S; Tahirovic E; Töpper A; Mehrhof F; Prettin C; Putnikovic B; Neskovic AN; Krotin M; Sakac D; Lainscak M; Edelmann F; Wachter R; Rau T; Eschenhagen T; Doehner W; Anker SD; Waagstein F; Herrmann-Lingen C; Gelbrich G; Dietz R;
Eur J Heart Fail; 2011 Jun; 13(6):670-80. PubMed ID: 21429992
[TBL] [Abstract][Full Text] [Related]
15. Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure.
Baudhuin LM; Miller WL; Train L; Bryant S; Hartman KA; Phelps M; Larock M; Jaffe AS
Am J Cardiol; 2010 Aug; 106(3):402-8. PubMed ID: 20643254
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
Hori M; Nagai R; Izumi T; Matsuzaki M
Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
[TBL] [Abstract][Full Text] [Related]
17. Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD).
Scherer M; Düngen HD; Inkrot S; Tahirović E; Lashki DJ; Apostolović S; Edelmann F; Wachter R; Loncar G; Haverkamp W; Neskovic A; Herrmann-Lingen C
Eur J Intern Med; 2013 Jun; 24(4):333-8. PubMed ID: 23375618
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
[TBL] [Abstract][Full Text] [Related]
19. Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.
Gelbrich G; Edelmann F; Inkrot S; Lainscak M; Apostolovic S; Neskovic AN; Waagstein F; Loeffler M; Anker SD; Dietz R; Düngen HD;
Int J Cardiol; 2012 Feb; 155(1):160-6. PubMed ID: 22133470
[TBL] [Abstract][Full Text] [Related]
20. Bisoprolol and heart failure: new frontiers.
Chopra HK
Indian Heart J; 2010; 62(1):7-12. PubMed ID: 21180027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
